GHP Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$853K Hold
50,884
0.04% 278
2025
Q1
$782K Buy
50,884
+18,819
+59% +$289K 0.04% 277
2024
Q4
$707K Hold
32,065
0.03% 283
2024
Q3
$578K Buy
32,065
+30,265
+1,681% +$545K 0.03% 293
2024
Q2
$29.3K Hold
1,800
﹤0.01% 548
2024
Q1
$25.4K Sell
1,800
-200
-10% -$2.82K ﹤0.01% 556
2023
Q4
$20.9K Hold
2,000
﹤0.01% 566
2023
Q3
$17.3K Hold
2,000
﹤0.01% 618
2023
Q2
$19.6K Sell
2,000
-400
-17% -$3.91K ﹤0.01% 588
2023
Q1
$21.2K Hold
2,400
﹤0.01% 578
2022
Q4
$21.9K Hold
2,400
﹤0.01% 571
2022
Q3
$19K Hold
2,400
﹤0.01% 585
2022
Q2
$18K Hold
2,400
﹤0.01% 591
2022
Q1
$23K Buy
+2,400
New +$23K ﹤0.01% 591
2019
Q2
Sell
-26,023
Closed -$408K 310
2019
Q1
$408K Buy
26,023
+4,300
+20% +$67.4K 0.05% 238
2018
Q4
$335K Sell
21,723
-200
-0.9% -$3.08K 0.05% 247
2018
Q3
$472K Buy
21,923
+620
+3% +$13.3K 0.06% 228
2018
Q2
$518K Hold
21,303
0.07% 225
2018
Q1
$364K Hold
21,303
0.05% 245
2017
Q4
$404K Buy
21,303
+7,750
+57% +$147K 0.06% 242
2017
Q3
$239K Buy
13,553
+200
+1% +$3.53K 0.04% 273
2017
Q2
$444K Buy
13,353
+3,030
+29% +$101K 0.07% 236
2017
Q1
$331K Hold
10,323
0.06% 256
2016
Q4
$374K Hold
10,323
0.07% 239
2016
Q3
$475K Buy
10,323
+500
+5% +$23K 0.1% 212
2016
Q2
$493K Hold
9,823
0.11% 205
2016
Q1
$526K Sell
9,823
-400
-4% -$21.4K 0.12% 197
2015
Q4
$671K Sell
10,223
-152
-1% -$9.98K 0.16% 157
2015
Q3
$586K Hold
10,375
0.15% 163
2015
Q2
$642K Hold
10,375
0.16% 156
2015
Q1
$646K Buy
10,375
+170
+2% +$10.6K 0.17% 153
2014
Q4
$587K Sell
10,205
-150
-1% -$8.63K 0.16% 152
2014
Q3
$557K Buy
10,355
+60
+0.6% +$3.23K 0.16% 151
2014
Q2
$540K Hold
10,295
0.16% 153
2014
Q1
$544K Buy
10,295
+240
+2% +$12.7K 0.17% 144
2013
Q4
$403K Sell
10,055
-400
-4% -$16K 0.13% 174
2013
Q3
$395K Hold
10,455
0.14% 169
2013
Q2
$410K Buy
+10,455
New +$410K 0.16% 156